In this study, we identified a CRC liver metastasis-specific cholesterol metabolic pathway involving the activation of SREBP2-dependent cholesterol biosynthesis, which is required for the colonization growth of CRC in the liver. The gene discussed is SREBF2; the disease is colorectal carcinoma.